Morgan Stanley Initiates Theravance at Underweight

Symbols: THRX
Share

Morgan Stanley has initiated coverage on Theravance (NASDAQ: THRX) with an Underweight rating and $12 price target.


 
 
< Previous
Morgan Stanley Downgrades Cloud Peak Energy to Equal-weight
Next >
Credit Suisse Upgrades Aon to Neutral
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust

Special Offers:
Quick Cash Advance